Organon & Co (OGN)
18.67
+0.06
(+0.32%)
USD |
NYSE |
May 01, 12:17
Organon Price: 18.67 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 18.84 | 18.92 | 18.56 | 18.61 | 2.338M |
Apr 29, 2024 | 18.69 | 19.04 | 18.69 | 18.90 | 2.159M |
Apr 26, 2024 | 18.43 | 18.68 | 18.33 | 18.55 | 2.050M |
Apr 25, 2024 | 18.62 | 18.73 | 18.20 | 18.42 | 1.542M |
Apr 24, 2024 | 18.44 | 18.75 | 18.11 | 18.71 | 1.999M |
Apr 23, 2024 | 17.96 | 18.54 | 17.82 | 18.52 | 1.699M |
Apr 22, 2024 | 17.97 | 18.11 | 17.79 | 18.00 | 1.551M |
Apr 19, 2024 | 17.88 | 18.02 | 17.38 | 17.82 | 3.612M |
Apr 18, 2024 | 17.90 | 18.24 | 17.81 | 17.86 | 2.130M |
Apr 17, 2024 | 17.89 | 17.92 | 17.43 | 17.87 | 2.799M |
Apr 16, 2024 | 17.55 | 17.92 | 17.38 | 17.79 | 2.503M |
Apr 15, 2024 | 17.60 | 17.92 | 17.58 | 17.71 | 3.049M |
Apr 12, 2024 | 18.19 | 18.24 | 17.33 | 17.45 | 2.976M |
Apr 11, 2024 | 18.39 | 18.47 | 17.92 | 18.28 | 1.855M |
Apr 10, 2024 | 18.01 | 18.22 | 18.00 | 18.16 | 2.566M |
Apr 09, 2024 | 18.15 | 18.43 | 18.10 | 18.41 | 1.646M |
Apr 08, 2024 | 18.03 | 18.18 | 17.67 | 18.16 | 1.286M |
Apr 05, 2024 | 17.80 | 18.02 | 17.52 | 17.86 | 2.011M |
Apr 04, 2024 | 18.17 | 18.23 | 17.87 | 17.87 | 1.445M |
Apr 03, 2024 | 18.10 | 18.20 | 17.86 | 17.91 | 2.221M |
Apr 02, 2024 | 18.26 | 18.33 | 18.04 | 18.13 | 1.564M |
Apr 01, 2024 | 18.81 | 18.82 | 18.34 | 18.50 | 1.482M |
Mar 28, 2024 | 18.50 | 18.93 | 18.42 | 18.80 | 2.254M |
Mar 27, 2024 | 18.25 | 18.50 | 18.18 | 18.45 | 1.647M |
Mar 26, 2024 | 17.97 | 18.19 | 17.86 | 18.12 | 1.798M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
10.95
Minimum
Nov 16 2023
39.36
Maximum
Mar 02 2022
26.41
Average
28.19
Median
Price Benchmarks
Merck & Co Inc | 128.91 |
Alnylam Pharmaceuticals Inc | 145.87 |
Amgen Inc | 276.51 |
Biogen Inc | 217.03 |
Pacira BioSciences Inc | 26.88 |
Price Related Metrics
PE Ratio | 4.668 |
PS Ratio | 0.7640 |
PEG Ratio | 0.4087 |
Price to Free Cash Flow | 8.893 |
Earnings Yield | 21.42% |
Market Cap | 4.773B |
PEGY Ratio | 0.2677 |
Operating PE Ratio | 3.605 |
Normalized PE Ratio | 4.302 |